Cargando…

Seroprevalence and attainment of herd immunity against SARS CoV-2: A modelling study

OBJECTIVE: The present study aims to predict the likelihood of and likely time required to attain herd immunity against COVID-19 in New Delhi due to natural infection. METHOD: An ODE-based mathematical model was constructed by extending the classical SEIR model to predict the seroprevalence rate. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Paul, Abhijit, Kadnur, Harshith B., Ray, Animesh, Chatterjee, Samrat, Wig, Naveet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797069/
https://www.ncbi.nlm.nih.gov/pubmed/35136763
http://dx.doi.org/10.4103/jfmpc.jfmpc_830_21
_version_ 1784641461020524544
author Paul, Abhijit
Kadnur, Harshith B.
Ray, Animesh
Chatterjee, Samrat
Wig, Naveet
author_facet Paul, Abhijit
Kadnur, Harshith B.
Ray, Animesh
Chatterjee, Samrat
Wig, Naveet
author_sort Paul, Abhijit
collection PubMed
description OBJECTIVE: The present study aims to predict the likelihood of and likely time required to attain herd immunity against COVID-19 in New Delhi due to natural infection. METHOD: An ODE-based mathematical model was constructed by extending the classical SEIR model to predict the seroprevalence rate. We estimated the parameter values for Delhi using available data (reported cases and the seroprevalence rate) and used them for future prediction. Also, changes in the seroprevalence rate with different possibilities of reinfection were predicted. RESULTS: Maximum seroprevalence rate obtained through our model is 31.65% and also a reduction in the seroprevalence rate was observed for the upcoming one month (month of January, 2021) due to the reduced transmission rate. After increasing the transmission rate to the value same as the third wave in New Delhi, we obtained a maximum value of 54.96%. This maximum value significantly decreased with the reduction in the reinfection possibilities. Also, a little impact of the duration of persistence of antibodies, 180 vs 105 days, was observed on the maximum seroprevalence. CONCLUSION: This modelling study suggests that natural infection alone, as gauged by serial sero-surveys, may not result in attainment of herd immunity in the state of Delhi.
format Online
Article
Text
id pubmed-8797069
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-87970692022-02-07 Seroprevalence and attainment of herd immunity against SARS CoV-2: A modelling study Paul, Abhijit Kadnur, Harshith B. Ray, Animesh Chatterjee, Samrat Wig, Naveet J Family Med Prim Care Original Article OBJECTIVE: The present study aims to predict the likelihood of and likely time required to attain herd immunity against COVID-19 in New Delhi due to natural infection. METHOD: An ODE-based mathematical model was constructed by extending the classical SEIR model to predict the seroprevalence rate. We estimated the parameter values for Delhi using available data (reported cases and the seroprevalence rate) and used them for future prediction. Also, changes in the seroprevalence rate with different possibilities of reinfection were predicted. RESULTS: Maximum seroprevalence rate obtained through our model is 31.65% and also a reduction in the seroprevalence rate was observed for the upcoming one month (month of January, 2021) due to the reduced transmission rate. After increasing the transmission rate to the value same as the third wave in New Delhi, we obtained a maximum value of 54.96%. This maximum value significantly decreased with the reduction in the reinfection possibilities. Also, a little impact of the duration of persistence of antibodies, 180 vs 105 days, was observed on the maximum seroprevalence. CONCLUSION: This modelling study suggests that natural infection alone, as gauged by serial sero-surveys, may not result in attainment of herd immunity in the state of Delhi. Wolters Kluwer - Medknow 2021-11 2021-11-29 /pmc/articles/PMC8797069/ /pubmed/35136763 http://dx.doi.org/10.4103/jfmpc.jfmpc_830_21 Text en Copyright: © 2021 Journal of Family Medicine and Primary Care https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Paul, Abhijit
Kadnur, Harshith B.
Ray, Animesh
Chatterjee, Samrat
Wig, Naveet
Seroprevalence and attainment of herd immunity against SARS CoV-2: A modelling study
title Seroprevalence and attainment of herd immunity against SARS CoV-2: A modelling study
title_full Seroprevalence and attainment of herd immunity against SARS CoV-2: A modelling study
title_fullStr Seroprevalence and attainment of herd immunity against SARS CoV-2: A modelling study
title_full_unstemmed Seroprevalence and attainment of herd immunity against SARS CoV-2: A modelling study
title_short Seroprevalence and attainment of herd immunity against SARS CoV-2: A modelling study
title_sort seroprevalence and attainment of herd immunity against sars cov-2: a modelling study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797069/
https://www.ncbi.nlm.nih.gov/pubmed/35136763
http://dx.doi.org/10.4103/jfmpc.jfmpc_830_21
work_keys_str_mv AT paulabhijit seroprevalenceandattainmentofherdimmunityagainstsarscov2amodellingstudy
AT kadnurharshithb seroprevalenceandattainmentofherdimmunityagainstsarscov2amodellingstudy
AT rayanimesh seroprevalenceandattainmentofherdimmunityagainstsarscov2amodellingstudy
AT chatterjeesamrat seroprevalenceandattainmentofherdimmunityagainstsarscov2amodellingstudy
AT wignaveet seroprevalenceandattainmentofherdimmunityagainstsarscov2amodellingstudy